Revolution Medicines target price raised to $265 from $248
RVMD•Raymond James raised its target price for Revolution Medicines to $265 from $248.
Related News
Teads names Michael Coyle CFO, succeeding Jason Kiviat
TEAD•
Paycom Software, Inc.: BTIG cuts to neutral from buy
PAYC•
Real REMAX Group Q3 revenue rises 28%, beats estimates
REAX•
Bank of England delivers first rate hike in three years, gilt yields rise
TLT•
LCI Industries Q3 sales fall 4%, miss estimates
LCII•